INTERNATIONAL PATENT: JANSSEN BIOTECH, INC. FILES APPLICATION FOR "BISPECIFIC ANTIBODY TARGETING EMR2 (CD312) AND THE T-CELL RECEPTOR TRBV19"

GENEVA, Dec. 1 -- JANSSEN BIOTECH, INC. (800/850 Ridgeview DriveHorsham, Pennsylvania 19044) filed a patent application (PCT/IB2025/055320) for "BISPECIFIC ANTIBODY TARGETING EMR2 (CD312) AND THE T-CELL RECEPTOR TRBV19" on May 22, 2025. With publication no. WO/2025/243243, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MANIERI, Nicholas Andrew (1400 McKean RoadSpring House, Pennsylvania 19477), DEREBE, Mehabaw Getahun (1400 McKean RoadSpring House, Pennsylvania 19477), EL ASHKAR, Sara (Turnhoutseweg 302340 Beerse), PHILI...